A comparative study of ProGRP and CEA as serological markers in small cell lung cancer treatment
Both ProGRP and CEA are significant serological markers in SCLC patients, with ProGRP showing a stronger correlation with tumor stage and treatment response. ProGRP may serve as a superior independent predictor of treatment response and disease progression compared to CEA. These findings support the incorporation of ProGRP in SCLC treatment monitoring protocols.
Authors
- Mingjie Yu (ORCID: https://orcid.org/0000-0001-8938-5514)
- Ping Wang (ORCID: https://orcid.org/0000-0001-6300-6504)
Institutions
- Bozhou People's Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2024-09-27
- DOI
- https://doi.org/10.1007/s12672-024-01323-3
- Citations
- 8
- Primary Topic
- Lung Cancer Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.26